IWGDF guidance on use of interventions to enhance the healing of chronic ulcers of the foot in diabetes.
Department of Diabetes and Endocrinology, Derby Teaching Hospitals NHS FT, Derby, UK.
F L
FL
Game
Department of Plastic Surgery, Medstar Georgetown University. Hospital, Washington DC, USA.
C
C
Attinger
Pitié-Salpêtrière Hospital, APHP, Paris 6 University, ICAN, Paris, France.
A
A
Hartemann
St George's Vascular Institute, St George's Healthcare NHS Trust, London, UK.
R J
RJ
Hinchliffe
Department of Endocrinology, Skåne University Hospital, Malmö, Sweden.
M
M
Löndahl
Vice-Chancellors' Office, Cardiff University, Cardiff, UK.
P E
PE
Price
Department of Diabetes and Endocrinology, Nottingham University Hospitals NHS Trust, Nottingham, UK.
W J
WJ
Jeffcoate
D002908:Chronic Disease; D003131:Combined Modality Therapy / Q000009:adverse effects / Q000639:trends; D017719:Diabetic Foot / Q000534:rehabilitation / Q000628:therapy*; D019317:Evidence-Based Medicine; D014943:Global Health; D006801:Humans; D006931:Hyperbaric Oxygenation / Q000009:adverse effects / Q000639:trends; D007390:International Agencies; D023821:Limb Salvage / Q000009:adverse effects / Q000639:trends; D054843:Negative-Pressure Wound Therapy / Q000009:adverse effects / Q000639:trends; D057285:Precision Medicine; D011787:Quality of Health Care; D035703:Therapies, Investigational / Q000009:adverse effects* / Q000639:trends; D014945:Wound Healing